Trial intelligence / Profile preview

KLH-2109 in Endometriosis

NCT01395940Phase 2Completed

Sponsor
Kissei Pharmaceutical Co., Ltd.
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of linzagolix in endometriosis, sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.

02

Drugs

linzagolix
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT01395940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01395940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call